NEW YORK, April 28, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
Pharmaceutical Key Trends 2011 – Prescription Pharmaceutical Sales
Overview
http://www.reportlinker.com/p0460810/Pharmaceutical-Key-Trends-2011—Prescription-Pharmaceutical-Sales-Overview.html
Introduction
Prescription pharmaceutical sales in the world’s major markets
(US, France, Germany, Italy, Spain, the UK, Japan, Australia,
Brazil, Russia, China and India) totaled $555bn in 2009, having
grown by 6.3% during 2008–09, and at a compound annual growth
rate (CAGR) of 5.6% between 2005 and 2009.
Features and benefits
* Examines the prescription pharmaceutical sales growth trends
across the various different therapy areas
* Assesses the leading prescription pharmaceutical brands across
the each of the 12 major pharma markets
* Profiles the leading multinational and domestic pharma
companies operating in each of the 12 major pharma markets
* Analyzes the forecast sales according to lifecycle stage of
drug, molecule type, source of drug, geographical market, therapy
area and formulation
Highlights
The US prescription pharmaceutical market generated half (50.3%)
of the sales of the 12 markets analyzed, with $279bn in 2009, with
sales having grown by 5.0% (CAGR, 2005–09) and 5.5%
(2008–09). However, future sales growth will be shaped by
three key events: the US economic downturn, healthcare reform and
the patent cliff.
Pharma is set to loose approximately $108bn in sales due to the
patent cl
‘/>”/>
SOURCE